Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period

Neurodegenerative Diseases

Volumn 13, Issue 1, 2013, Pages 9-16

  Van Duijn, Erik ^a,b   Reedeker, Nanda ^a   Giltay, Erik J ^a   Eindhoven, Daniëlle ^a   Roos, Raymund A C ^a   Van Der Mast, Rose C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Centre for Mental Health Care Delfland   (Netherlands)

Author keywords

Apathy; Depression; Huntington's disease; Irritability; Movement disorders; Neuropsychiatry

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; APATHY; ARTICLE; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENE MUTATION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTOR DYSFUNCTION; PRIORITY JOURNAL; PROBLEMS BEHAVIOR ASSESSMENT; UNIFIED HUNTINGTON DISEASE RATING SCALE; CAG REPEAT; MINI MENTAL STATE EXAMINATION;

ADULT; APATHY; DEPRESSION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; IRRITABLE MOOD; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84891087708     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000343210     Document Type: Article

References (30)

1. Walker FO: Huntington's disease. Lancet 2007; 369: 218-228. (Pubitemid 46107685)
2. Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
3. Phillips W, Shannon KM, Barker RA: The current clinical management of Huntington's disease. Mov Disord 2008; 23: 1491-1504.
4. van Duijn E, Kingma EM, van der Mast RC: Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007; 19: 441-448. (Pubitemid 350156103)
5. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC, Predict-HD Investigators of the Huntington Study Group: Psychiatric symptoms in Huntington's disease before diagnosis: the Predict-HD study. Biol Psychiatry 2007; 62: 1341-1346. (Pubitemid 350180721)
6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 2000.
7. Huntington Study Group: Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996; 11: 136-142.
8. Craufurd D, Thompson JC, Snowden JS: Behavioural changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 219-226.
9. Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R, McDowell B, Turner B, Huntington Study Group: Depression and stages of Huntington's disease. J Neuropsychiatry Clin Neurosci 2005; 17: 496-502. (Pubitemid 41790050)
10. Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RAC: Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen Hosp Psychiatry 2008; 30: 155-161. (Pubitemid 351255558)
11. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC, TRACK-HD investigators: Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009; 8: 791-801.
12. Burns A, Folstein S, Brandt J, Folstein M: Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nerv Ment Dis 1990; 178: 20-26. (Pubitemid 20175040)
13. van Duijn E, Giltay EJ, Zitman FG, Roos RAC, van der Mast RC: Measurement of psychopathology in Huntington's disease: the critical role of caregivers. J Nerv Ment Dis 2010; 198: 329-333.
14. Reedeker W, Bouwens JA, van Duijn E, Giltay EJ, Roos RAC, van der Mast RC: Incidence, course and predictors of apathy in Huntington's disease: a two-year prospective study. J Neuropsychiatry Clin Neurosci 2011; 23: 434-441.
15. Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL: Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 2001; 71: 310-314. (Pubitemid 32772526)
16. van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RAC, van der Mast RC: Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 2008; 69: 1804-1810.
17. Vassos E, Panas M, Kladi A, Vassilopoulos D: Effect of CAG repeat length on psychiatric disorders in Huntington's disease. J Psychiatr Res 2008; 42: 544-549. (Pubitemid 351400481)
18. Shoulson I, Fahn S: Huntington disease: clinical care and evaluation. Neurology 1979; 29: 1-3. (Pubitemid 9051179)
19. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
20. Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB Jr, Siemers E, Shoulson I: Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 2000; 54: 452-458. (Pubitemid 30078083)
21. Rickards H, De Souza J, van Walsem M, van Duijn E, Simpson SA, Squitieri F, Landwehrmeyer B, European Huntington's Disease Network: Factor analysis of behavioural symptoms in Huntington's disease. J Neurol Neurosurg Psychiatry 2011; 82: 411-412.
22. Berrios GE, Wagle AC, Markova IS, Wagle SA, Rosser A, Hodges JR: Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects. Acta Psychiatr Scand 2002; 105: 224-230. (Pubitemid 34280696)
23. Kirkwood SC, Siemers E, Viken R, Hodes ME, Conneally PM, Christian JC, Foroud T: Longitudinal personality changes among presymptomatic Huntington disease gene carriers. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 192-197. (Pubitemid 35006774)
24. Julien CL, Thompson JC, Wild S, Yardumian P, Snowden JS, Turner G, Craufurd D: Psychiatric disorders in pre-clinical Huntington's disease. J Neurol Neurosurg Psychiatry 2007; 78: 939-943. (Pubitemid 47310828)
25. Orth M, European Huntington's Disease Network: Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. PLoS Curr 2010, DOI: 10.1371/ currents.RRN1184.
26. Vassos E, Panas M, Kladi A, Vassilopoulos D: Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease. Biol Psychiatry 2007; 62: 1347-1352. (Pubitemid 350186152)
27. Tabrizi SJ, Scahili RI, Durr A, Roos RAC, Leavitt BR, Jones R, Landwehrmeyer B, et al, TRACK-HD Investigators: Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 2011; 10: 31-42.
28. Gargiulo M, Lejeune S, Tanguy ML, Lahlou-Laforet K, Faudet A, Cohen D, Feingold J, Durr A: Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet 2009; 17: 165-171.
29. Kirkwood SC, Su JL, Conneally PM, Foroud T: Progression of symptoms in the early and middle stages of Huntington's disease. Arch Neurol 2001; 58: 273-278. (Pubitemid 32163165)
30. Paulsen JS, Wang CH, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, van Kammen DP, PREDICT-HD Investigators of the Huntington Study Group: Challenges assessing clinical endpoints in early Huntington disease. Mov Disord 2010; 25: 2595-2603.